Press Alt+1 for screen-reader mode, Alt+0 to cancelAccessibility Screen-Reader Guide, Feedback, and Issue Reporting | New window
timothy sykes logo

Stock News

Hinge Health: Is It Too Late to Buy?

Bryce TuoheyAvatar
Written by Bryce Tuohey Reviewed by Matt Monaco Fact-checked by Bryce Tuohey
Updated 8/6/2025, 5:03 pm ET | 6 min
Hinge Health: Is It Too Late to Buy? Thumbnail

In this article Last trade Aug, 06 5:27 PM

  • HNGE+25.72%
    HNGE - NYSEHinge Health Inc. Class A
    $60.62+12.40 (+25.72%)
    Volume:  3.28M
    Float:  24.75M
    $51.99Day Low/High$62.00

Hinge Health Inc.’s stocks have been trading up by 24.45 percent following important strategic partnership announcements.

  • Analysts suggest that recent innovations in telehealth technologies have driven investors’ confidence, leading to a sharp increase in demand for Hinge Health shares.

  • Market insiders report that a strategic partnership with a renowned healthcare provider is on the horizon. This prospective collaboration could potentially boost market expansion and revenue streams exponentially.

  • Hinge Health’s revamped business model and recent talks of possible mergers are rumored to have caught the attention of some major stakeholders.

  • Financial experts believe that Hinge Health’s focus on AI-driven healthcare solutions positions it as an attractive investment option for forward-thinking investors.

Candlestick Chart

Live Update At 17:03:14 EST: On Wednesday, August 06, 2025 Hinge Health Inc. stock [NYSE: HNGE] is trending up by 24.45%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Earnings and Financial Metrics Overview

Traders often feel the urgency to make moves based on fear of missing out, particularly in a volatile market. However, patience and discernment are key. As millionaire penny stock trader and teacher Tim Sykes, says, “There is always another play around the corner; don’t chase just because you feel FOMO.” Understanding this helps traders avoid hasty decisions and focus on strategic plays that align with their analysis and risk tolerance, rather than succumbing to the impulsive rush that can lead to unnecessary losses.

The latest earnings report from Hinge Health presented strong financial metrics, which revealed a mix of positive and alarming indicators. Their revenue clocked at approximately $390M, highlighting growth within the sector. However, net income from continuing operations stood at a moderate $17.13M, signaling potential challenges.

Taking a closer look, the earnings per share (EPS) for the quarter ended March 31, 2025, was dominantly positive at 7.91. Yet, with a pretax profit margin of 14.7% and leverage ratio data missing, stakeholders might lack complete optimism. The company has made substantial capital investments, with over $90M directed toward long-term investments.

While short-term liabilities weighed down the company by $267.48M, their working capital remained strong at approximately $350.78M. Asset turnover ratios were not available, yet management effectiveness levels, such as a return on equity of 27.65%, demonstrated a highly productive use of equity capital. Hinge Health’s beacon of financial health remains expansive yet requires prudent management to navigate forward.

Driving the Market: News Breakdown

Innovation Drives Stock Highs

By successfully integrating telehealth technologies, Hinge Health has emerged as a pioneering force within the digital healthcare landscape. They effectively bridged technology with medicine, catering to increased consumer expectations for versatile and modern healthcare services. As markets witnessed this leap, investor enthusiasm soared, propelling stock values.

Their autonomous AI solutions have ignited conversations around the intersection between healthcare and technology, pulling in attention from potential collaborators and innovators alike. This movement points towards further engagement opportunities, thus helping the company unlock substantial market potential.

Eyes on Strategic Partnerships

The whispers around a potential collaboration with a known healthcare provider have fueled existing interest in Hinge Health. The strategic partnership is speculated to bolster the company’s market outreach, presenting a synergistic relationship that can help both entities seize a larger slice of the healthcare pie. Such partnerships not only open up revenue streams but may also introduce efficiency and innovation.

More Breaking News

Business Reengineering and Possible Mergers

Aside from partnerships, Hinge Health’s initiative towards refining its business ethos showcases adaptability to shifting market conditions. Insights suggest that these realignments have enticed significant interest among larger investors who see potential mergers as an opportunity to capitalize on mutual growth trajectories.

The conjecture of an upcoming merger has led to significant stock interest. Investors seemingly appreciate the proactive measure towards solidifying the corporation’s market presence.

AI Healthcare: Attracting Investor Attention

Finally, Hinge Health’s embracement of AI-driven solutions in the healthcare sphere has captivated market interest through its ability to reshape patient care. By understanding the burgeoning demand for digital health solutions, the forward-thinking approach gives Hinge Health an edge. Consequently, the establishment of AI in healthcare appears to be a primary driver of the current market behavior.

In conclusion, the wave of technological adoption, strategic alignments, and AI advancements collectively drives the allure of Hinge Health. As millionaire penny stock trader and teacher Tim Sykes says, “It’s not about how much money you make; it’s about how much money you keep.” While stock volatility remains an intrinsic behavior within the market spectrum, the company’s strategic efforts spotlight its potential. Thus, one may ponder whether the current valuation accurately reflects Hinge Health’s trajectory or if a trading position now could yield significant future gains.

This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.

Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:

Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:

How much has this post helped you?

(0 votes, average: 0 out of 5)
Leave a reply
Author card Timothy Sykes picture

Bryce Tuohey

Mentor and Trainer at StocksToTrade.com, Lead Mentor at Small Cap Rockets and To The Moon Report
Bryce’s first pattern was buying into strength in breakouts. But he noticed when they didn’t work, he took bigger losses. When the OTC market got hot, Bryce learned to dip buy the inevitable panics. He adapted his breakout strategy and now buys consolidation and trend breaks. His goal is to have better risk/reward and get an entry before multi-day listed breakouts.
Read More

* Results are not typical and will vary from person to person. Making money trading stocks takes time, dedication, and hard work. There are inherent risks involved with investing in the stock market, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk. See Terms of Service here

The available research on day trading suggests that most active traders lose money. Fees and overtrading are major contributors to these losses.

A 2000 study called “Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors” evaluated 66,465 U.S. households that held stocks from 1991 to 1996. The households that traded most averaged an 11.4% annual return during a period where the overall market gained 17.9%. These lower returns were attributed to overconfidence.

A 2014 paper (revised 2019) titled “Learning Fast or Slow?” analyzed the complete transaction history of the Taiwan Stock Exchange between 1992 and 2006. It looked at the ongoing performance of day traders in this sample, and found that 97% of day traders can expect to lose money from trading, and more than 90% of all day trading volume can be traced to investors who predictably lose money. Additionally, it tied the behavior of gamblers and drivers who get more speeding tickets to overtrading, and cited studies showing that legalized gambling has an inverse effect on trading volume.

A 2019 research study (revised 2020) called “Day Trading for a Living?” observed 19,646 Brazilian futures contract traders who started day trading from 2013 to 2015, and recorded two years of their trading activity. The study authors found that 97% of traders with more than 300 days actively trading lost money, and only 1.1% earned more than the Brazilian minimum wage ($16 USD per day). They hypothesized that the greater returns shown in previous studies did not differentiate between frequent day traders and those who traded rarely, and that more frequent trading activity decreases the chance of profitability.

These studies show the wide variance of the available data on day trading profitability. One thing that seems clear from the research is that most day traders lose money .

Millionaire Media 66 W Flagler St. Ste. 900 Miami, FL 33130 United States (888) 878-3621 This is for information purposes only as Millionaire Media LLC nor Timothy Sykes is registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund. Millionaire Media LLC and Timothy Sykes cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. Millionaire Media LLC and Timothy Sykes in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, Millionaire Media LLC and Timothy Sykes accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, nor should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns.

Citations for Disclaimer

Barber, Brad M. and Odean, Terrance, Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors. Available at SSRN: “Day Trading for a Living?”

Barber, Brad M. and Lee, Yi-Tsung and Liu, Yu-Jane and Odean, Terrance and Zhang, Ke, Learning Fast or Slow? (May 28, 2019). Forthcoming: Review of Asset Pricing Studies, Available at SSRN: “https://ssrn.com/abstract=2535636”

Chague, Fernando and De-Losso, Rodrigo and Giovannetti, Bruno, Day Trading for a Living? (June 11, 2020). Available at SSRN: “https://ssrn.com/abstract=3423101”

ts swipe photo
Get Tim Sykes’ Daily Trade Ideas for $0
Claim Free Alerts
notification icon
Subscribe to receive notifications